Watkins, Timothy R.

Anemia in Critical Illness: Insights into Etiology, Consequences, and Management

Hayden, S. J., Albert, T. J., Watkins, T. R., & Swenson, E. R. (2012) · American Journal of Respiratory and Critical Care Medicine

Blood transfusion and managementErythropoietin and Anemia Treatment

Cited by 271

A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury*

Stapleton, R. D., Martin, T. R., Weiss, N. S., Crowley, J. J., Gundel, S. J., Nathens, A. B., Akhtar, S. R., Ruzinski, J. T., Caldwell, E., Curtis, J. R., et al. (2011) · Critical Care Medicine

Respiratory Support and MechanismsClinical Nutrition and Gastroenterology

Cited by 173

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials

Maher, T. M., Ford, P., Brown, K. K., Costabel, U., Cottin, V., Danoff, S. K., Groenveld, I., Helmer, E., Jenkins, R. G., Milner, J., et al. (2023) · JAMA

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 148

AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases

Iyer, J. S., Juyal, D., Le, Q., Shanis, Z., Pokkalla, H., Pouryahya, M., Pedawi, A., Stanford-Moore, S. A., Biddle-Snead, C., Carrasco-Zevallos, O., et al. (2024) · Nature Medicine

Liver Disease Diagnosis and TreatmentArtificial Intelligence in Healthcare and Education

Cited by 54